Arkolith/Insider Trading/CRSP/Form 4

Prasad Raju

Chief Financial OfficerCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Jan 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Option exercise(M)35K$45.15$1.6M42K
Jan 22, 2026Sell(S)35K$60.19$2.1M7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 22, 2026Option exercise(M)35K—$042K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-022845) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML